Annual Operating Profit
-$4.70 M
-$131.00 K-2.87%
31 March 2024
Summary:
Sonoma Pharmaceuticals annual operaing income is currently -$4.70 million, with the most recent change of -$131.00 thousand (-2.87%) on 31 March 2024. During the last 3 years, it has fallen by -$1.25 million (-36.30%). SNOA annual operating profit is now -621.18% below its all-time high of $902.00 thousand, reached on 31 March 2004.SNOA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$850.00 K
+$323.00 K+27.54%
30 September 2024
Summary:
Sonoma Pharmaceuticals quarterly operating income is currently -$850.00 thousand, with the most recent change of +$323.00 thousand (+27.54%) on 30 September 2024. Over the past year, it has dropped by -$6000.00 (-0.71%). SNOA quarterly operating profit is now -116.84% below its all-time high of $5.05 million, reached on 30 September 2006.SNOA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$4.28 M
+$358.00 K+7.73%
30 September 2024
Summary:
Sonoma Pharmaceuticals TTM operating income is currently -$4.28 million, with the most recent change of +$358.00 thousand (+7.73%) on 30 September 2024. Over the past year, it has increased by +$163.00 thousand (+3.67%). SNOA TTM operating profit is now -520.45% below its all-time high of $1.02 million, reached on 31 December 2004.SNOA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SNOA Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.9% | -0.7% | +3.7% |
| 3 y3 years | -36.3% | +11.3% | +24.2% |
| 5 y5 years | +58.2% | +23.3% | +37.8% |
SNOA Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -36.3% | +20.1% | -16.3% | +72.2% | at high | +34.0% |
| 5 y | 5 years | -36.3% | +58.2% | -603.0% | +73.6% | -24.0% | +42.1% |
| alltime | all time | -621.2% | +79.0% | -116.8% | +96.3% | -520.5% | +81.4% |
Sonoma Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$850.00 K(-27.5%) | -$4.28 M(-7.7%) |
| June 2024 | - | -$1.17 M(-16.7%) | -$4.63 M(-1.4%) |
| Mar 2024 | -$4.70 M(+2.9%) | -$1.41 M(+66.9%) | -$4.70 M(+5.9%) |
| Dec 2023 | - | -$844.00 K(-30.1%) | -$4.44 M(-18.2%) |
| Sept 2023 | - | -$1.21 M(-2.6%) | -$5.43 M(+9.6%) |
| June 2023 | - | -$1.24 M(+8.1%) | -$4.95 M(+8.4%) |
| Mar 2023 | -$4.57 M(-22.4%) | -$1.15 M(-37.5%) | -$4.57 M(-29.5%) |
| Dec 2022 | - | -$1.83 M(+150.9%) | -$6.48 M(+15.6%) |
| Sept 2022 | - | -$731.00 K(-14.5%) | -$5.60 M(-4.0%) |
| June 2022 | - | -$855.00 K(-72.1%) | -$5.84 M(-0.8%) |
| Mar 2022 | -$5.89 M(+70.7%) | -$3.06 M(+219.4%) | -$5.89 M(+4.4%) |
| Dec 2021 | - | -$958.00 K(-0.6%) | -$5.64 M(+17.0%) |
| Sept 2021 | - | -$964.00 K(+6.6%) | -$4.82 M(+30.7%) |
| June 2021 | - | -$904.00 K(-67.9%) | -$3.69 M(+6.9%) |
| Mar 2021 | -$3.45 M(-53.3%) | -$2.81 M(+1939.1%) | -$3.45 M(-10.6%) |
| Dec 2020 | - | -$138.00 K(-181.7%) | -$3.86 M(-20.1%) |
| Sept 2020 | - | $169.00 K(-125.4%) | -$4.83 M(-23.2%) |
| June 2020 | - | -$665.00 K(-79.4%) | -$6.28 M(-15.0%) |
| Mar 2020 | -$7.39 M(-34.4%) | -$3.22 M(+191.0%) | -$7.39 M(+7.6%) |
| Dec 2019 | - | -$1.11 M(-13.9%) | -$6.87 M(-15.3%) |
| Sept 2019 | - | -$1.29 M(-27.3%) | -$8.11 M(-14.4%) |
| June 2019 | - | -$1.77 M(-34.5%) | -$9.48 M(-15.8%) |
| Mar 2019 | -$11.26 M(-20.7%) | -$2.70 M(+15.1%) | -$11.26 M(-15.4%) |
| Dec 2018 | - | -$2.35 M(-11.4%) | -$13.30 M(-6.0%) |
| Sept 2018 | - | -$2.65 M(-25.3%) | -$14.15 M(-1.4%) |
| June 2018 | - | -$3.55 M(-25.2%) | -$14.36 M(+1.2%) |
| Mar 2018 | -$14.19 M(+9.4%) | -$4.75 M(+48.4%) | -$14.19 M(+14.9%) |
| Dec 2017 | - | -$3.20 M(+12.0%) | -$12.35 M(-2.9%) |
| Sept 2017 | - | -$2.86 M(-15.5%) | -$12.72 M(-1.0%) |
| June 2017 | - | -$3.38 M(+16.2%) | -$12.85 M(-1.0%) |
| Mar 2017 | -$12.97 M(-11.8%) | -$2.91 M(-18.3%) | -$12.97 M(-5.1%) |
| Dec 2016 | - | -$3.56 M(+19.4%) | -$13.68 M(-4.4%) |
| Sept 2016 | - | -$2.99 M(-14.9%) | -$14.30 M(+8.6%) |
| June 2016 | - | -$3.51 M(-2.9%) | -$13.17 M(+10.0%) |
| Mar 2016 | -$14.71 M(+121.0%) | -$3.62 M(-13.7%) | -$11.97 M(+19.6%) |
| Dec 2015 | - | -$4.19 M(+125.5%) | -$10.01 M(+28.8%) |
| Sept 2015 | - | -$1.86 M(-19.6%) | -$7.77 M(+4.2%) |
| June 2015 | - | -$2.31 M(+39.9%) | -$7.46 M(+12.0%) |
| Mar 2015 | -$6.66 M(+10.0%) | -$1.65 M(-15.2%) | -$6.66 M(-6.4%) |
| Dec 2014 | - | -$1.95 M(+26.2%) | -$7.12 M(+6.0%) |
| Sept 2014 | - | -$1.54 M(+2.0%) | -$6.71 M(+4.2%) |
| June 2014 | - | -$1.51 M(-28.2%) | -$6.44 M(+6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | -$6.05 M(+79.3%) | -$2.11 M(+36.4%) | -$6.05 M(+13.6%) |
| Dec 2013 | - | -$1.55 M(+21.6%) | -$5.33 M(+19.4%) |
| Sept 2013 | - | -$1.27 M(+12.9%) | -$4.46 M(+11.3%) |
| June 2013 | - | -$1.13 M(-18.5%) | -$4.00 M(+18.7%) |
| Mar 2013 | -$3.37 M(-47.8%) | -$1.38 M(+103.2%) | -$3.37 M(-2.4%) |
| Dec 2012 | - | -$680.00 K(-16.8%) | -$3.46 M(-32.6%) |
| Sept 2012 | - | -$817.00 K(+65.1%) | -$5.13 M(+3.8%) |
| June 2012 | - | -$495.00 K(-66.2%) | -$4.94 M(-23.6%) |
| Mar 2012 | -$6.47 M(-13.8%) | -$1.47 M(-37.8%) | -$6.47 M(+1.2%) |
| Dec 2011 | - | -$2.35 M(+273.7%) | -$6.39 M(+4.5%) |
| Sept 2011 | - | -$630.00 K(-68.8%) | -$6.11 M(-14.2%) |
| June 2011 | - | -$2.02 M(+45.6%) | -$7.13 M(-5.0%) |
| Mar 2011 | -$7.50 M(-6.4%) | -$1.39 M(-33.3%) | -$7.50 M(-0.9%) |
| Dec 2010 | - | -$2.08 M(+26.3%) | -$7.57 M(+1.0%) |
| Sept 2010 | - | -$1.65 M(-31.3%) | -$7.50 M(-7.5%) |
| June 2010 | - | -$2.40 M(+64.7%) | -$8.11 M(+1.2%) |
| Mar 2010 | -$8.02 M(-53.7%) | -$1.46 M(-27.4%) | -$8.02 M(-9.0%) |
| Dec 2009 | - | -$2.00 M(-11.1%) | -$8.81 M(-11.4%) |
| Sept 2009 | - | -$2.25 M(-2.0%) | -$9.94 M(-30.5%) |
| June 2009 | - | -$2.30 M(+2.4%) | -$14.32 M(-16.2%) |
| Mar 2009 | -$17.31 M(-22.8%) | -$2.25 M(-28.4%) | -$17.09 M(-17.1%) |
| Dec 2008 | - | -$3.14 M(-52.6%) | -$20.62 M(-10.5%) |
| Sept 2008 | - | -$6.63 M(+30.6%) | -$23.03 M(+4.3%) |
| June 2008 | - | -$5.07 M(-12.2%) | -$22.08 M(-1.5%) |
| Mar 2008 | -$22.43 M(+15.1%) | -$5.78 M(+4.0%) | -$22.43 M(+0.0%) |
| Dec 2007 | - | -$5.55 M(-2.2%) | -$22.42 M(+2.0%) |
| Sept 2007 | - | -$5.68 M(+4.9%) | -$21.98 M(+95.3%) |
| June 2007 | - | -$5.42 M(-6.1%) | -$11.25 M(+140.8%) |
| Mar 2007 | -$19.48 M(-6.6%) | -$5.77 M(+12.8%) | -$4.67 M(-78.4%) |
| Dec 2006 | - | -$5.12 M(-201.3%) | -$21.59 M(+37.3%) |
| Sept 2006 | - | $5.05 M(+333.4%) | -$15.72 M(-22.3%) |
| June 2006 | - | $1.17 M(-105.1%) | -$20.23 M(-3.0%) |
| Mar 2006 | -$20.85 M(+27.8%) | -$22.68 M(-3120.5%) | -$20.85 M(+34.6%) |
| Dec 2005 | - | $751.00 K(+38.8%) | -$15.50 M(-2.6%) |
| Sept 2005 | - | $541.00 K(0.0%) | -$15.91 M(-1.3%) |
| June 2005 | - | $541.00 K(-103.1%) | -$16.11 M(-1.2%) |
| Mar 2005 | -$16.31 M(-1908.4%) | -$17.33 M(-5211.8%) | -$16.31 M(-1703.9%) |
| Dec 2004 | - | $339.00 K(0.0%) | $1.02 M(+50.0%) |
| Sept 2004 | - | $339.00 K(0.0%) | $678.00 K(+100.0%) |
| June 2004 | - | $339.00 K | $339.00 K |
| Mar 2004 | $902.00 K(-161.4%) | - | - |
| Mar 2003 | -$1.47 M(+898.6%) | - | - |
| Mar 2002 | -$147.00 K | - | - |
FAQ
- What is Sonoma Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual operating profit year-on-year change?
- What is Sonoma Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly operating profit year-on-year change?
- What is Sonoma Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals TTM operating profit year-on-year change?
What is Sonoma Pharmaceuticals annual operaing income?
The current annual operating profit of SNOA is -$4.70 M
What is the all time high annual operating profit for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual operaing income is $902.00 K
What is Sonoma Pharmaceuticals annual operating profit year-on-year change?
Over the past year, SNOA annual operaing income has changed by -$131.00 K (-2.87%)
What is Sonoma Pharmaceuticals quarterly operating income?
The current quarterly operating profit of SNOA is -$850.00 K
What is the all time high quarterly operating profit for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly operating income is $5.05 M
What is Sonoma Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, SNOA quarterly operating income has changed by -$6000.00 (-0.71%)
What is Sonoma Pharmaceuticals TTM operating income?
The current TTM operating profit of SNOA is -$4.28 M
What is the all time high TTM operating profit for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high TTM operating income is $1.02 M
What is Sonoma Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, SNOA TTM operating income has changed by +$163.00 K (+3.67%)